These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 27864438)

  • 41. Therapeutic options for low bone mineral density in HIV-infected subjects.
    Cotter AG; Mallon PW
    Curr HIV/AIDS Rep; 2012 Jun; 9(2):148-59. PubMed ID: 22528765
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Influence of anitiretroviral therapy on bone tissue metabolism in patients with HIV].
    Olczak A; Pawłowska M; Drózdz W
    Przegl Epidemiol; 2008; 62(1):155-62. PubMed ID: 18536239
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Is hand-grip another culprit for the risk of fractures in HIV-positive patients?
    Postorino MC; Torti C; Carè I; Pisani V; Strazzulla A; Vaccaro V; Costa C; Provenzano F; Mazzitelli M; Pujia A; Montalcini T
    New Microbiol; 2016 Jan; 39(1):61-4. PubMed ID: 26922987
    [TBL] [Abstract][Full Text] [Related]  

  • 44. British HIV Association guidelines for the routine investigation and monitoring of adult HIV-1-infected individuals 2011.
    Asboe D; Aitken C; Boffito M; Booth C; Cane P; Fakoya A; Geretti AM; Kelleher P; Mackie N; Muir D; Murphy G; Orkin C; Post F; Rooney G; Sabin C; Sherr L; Smit E; Tong W; Ustianowski A; Valappil M; Walsh J; Williams M; Yirrell D;
    HIV Med; 2012 Jan; 13(1):1-44. PubMed ID: 22171742
    [No Abstract]   [Full Text] [Related]  

  • 45. Reduced bone mineral density in HIV-infected patients: prevalence and associated factors.
    Cazanave C; Dupon M; Lavignolle-Aurillac V; Barthe N; Lawson-Ayayi S; Mehsen N; Mercié P; Morlat P; Thiébaut R; Dabis F;
    AIDS; 2008 Jan; 22(3):395-402. PubMed ID: 18195566
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Complications & side effects. At risk for bone breaking.
    TreatmentUpdate; 2007; 19(4):2-3. PubMed ID: 17955611
    [No Abstract]   [Full Text] [Related]  

  • 47. Osteoporosis in HIV-infected subjects: a combined effect of highly active antiretroviral therapy and HIV itself?
    Bongiovanni M; Fausto A; Cicconi P; Menicagli L; Melzi S; Ligabo VE; Cornalba G; Bini T; Sardanelli F; Monforte AD
    J Acquir Immune Defic Syndr; 2005 Dec; 40(4):503-4. PubMed ID: 16280710
    [No Abstract]   [Full Text] [Related]  

  • 48. Equivalent osteopenia in HIV-infected individuals studied before and during the era of highly active antiretroviral therapy.
    Lawal A; Engelson ES; Wang J; Heymsfield SB; Kotler DP
    AIDS; 2001 Jan; 15(2):278-80. PubMed ID: 11216941
    [No Abstract]   [Full Text] [Related]  

  • 49. Accelerated bone mineral loss in HIV-positive patients.
    Laurence J
    AIDS Read; 2000 Apr; 10(4):192, 200. PubMed ID: 10808594
    [No Abstract]   [Full Text] [Related]  

  • 50. Osteopenia in HIV-infected patients: is it the disease or is it the treatment?
    Knobel H; Guelar A; Vallecillo G; Nogués X; Díez A
    AIDS; 2001 Apr; 15(6):807-8. PubMed ID: 11371701
    [No Abstract]   [Full Text] [Related]  

  • 51. HIV and its effects on bone: a primer for rheumatologists.
    Gedmintas L; Solomon DH
    Curr Opin Rheumatol; 2012 Sep; 24(5):567-75. PubMed ID: 22820515
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Bone mineral loss in patients with human immunodeficiency virus infection].
    Olmos JM; González-Macías J
    Enferm Infecc Microbiol Clin; 2008 Apr; 26(4):212-9. PubMed ID: 18381041
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bone mineral density changes after 2 years of ARV treatment, compared to naive HIV-1-infected patients not on HAART.
    Rey D; Treger M; Sibilia J; Priester M; Bernard-Henry C; Cheneau C; Javier RM
    Infect Dis (Lond); 2015 Feb; 47(2):88-95. PubMed ID: 25426996
    [TBL] [Abstract][Full Text] [Related]  

  • 54. High prevalence of and progression to low bone mineral density in HIV-infected patients: a longitudinal cohort study.
    Bonjoch A; Figueras M; Estany C; Perez-Alvarez N; Rosales J; del Rio L; di Gregorio S; Puig J; Gómez G; Clotet B; Negredo E;
    AIDS; 2010 Nov; 24(18):2827-33. PubMed ID: 21045635
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The combination of FRAX and Ageing Male Symptoms scale better identifies treated HIV males at risk for major fracture.
    Pepe J; Isidori AM; Falciano M; Iaiani G; Salotti A; Diacinti D; Del Fiacco R; Sbardella E; Cipriani C; Piemonte S; Romagnoli E; Lenzi A; Minisola S
    Clin Endocrinol (Oxf); 2012 Nov; 77(5):672-8. PubMed ID: 22630782
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Reduced bone mineral density in human immunodeficiency virus-infected patients and its association with increased central adiposity and postload hyperglycemia.
    Brown TT; Ruppe MD; Kassner R; Kumar P; Kehoe T; Dobs AS; Timpone J
    J Clin Endocrinol Metab; 2004 Mar; 89(3):1200-6. PubMed ID: 15001610
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Protecting bone in long-term HIV positive patients receiving antiretrovirals.
    McGinty T; Mallon P
    Expert Rev Anti Infect Ther; 2016 Jun; 14(6):587-99. PubMed ID: 27189695
    [TBL] [Abstract][Full Text] [Related]  

  • 58. No brittle bones.
    Posit Aware; 2013-2014 Winter; 26(2):12-3. PubMed ID: 25376078
    [No Abstract]   [Full Text] [Related]  

  • 59. Report from Boston: the 12th Conference on Retroviruses and Opportunistic Infections (CROI). Reduced bone mineral density in HIV-infected patients.
    Brown TT
    Hopkins HIV Rep; 2005 May; 17(3):12-4, 16. PubMed ID: 16419313
    [No Abstract]   [Full Text] [Related]  

  • 60. Bone mineral abnormalities in persons with HIV infection: signal or noise?
    Singh K; Moyle GJ
    AIDS Read; 2006 Aug; 16(8):407-10, 413-8. PubMed ID: 16933375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.